ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,442.00
      2.14%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,129.65
      0.38%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biofrontera AG (BFRA)

      7. Biofrontera AG (BFRA) News

      BFRA

      Biofrontera (BFRA)

      Biofrontera AG
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BFRA
      DateTimeSourceHeadlineSymbolCompany
      03/14/20226:06AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BFRABiofrontera AG
      03/10/20226:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      03/09/20224:28PMEdgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:BFRABiofrontera AG
      03/09/20222:36PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BFRABiofrontera AG
      03/09/20222:29PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BFRABiofrontera AG
      02/25/20224:03PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
      02/24/20224:06PMEdgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:BFRABiofrontera AG
      02/24/20222:14PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      02/22/202210:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      02/14/20222:05PMGlobeNewswire Inc.Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costsNASDAQ:BFRABiofrontera AG
      02/01/202210:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      01/13/20229:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/14/20212:24PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/13/202110:23AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/08/20218:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/02/202110:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/02/20217:37AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      12/02/20216:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/29/20214:02PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BFRABiofrontera AG
      11/29/20211:13PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/29/202110:24AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/24/202110:13AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/19/202111:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/19/20218:45AMGlobeNewswire Inc.Biofrontera AG announces mediation resultsNASDAQ:BFRABiofrontera AG
      11/18/20216:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/17/20215:00PMGlobeNewswire Inc.Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021NASDAQ:BFRABiofrontera AG
      11/16/202111:41AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/16/20219:01AMGlobeNewswire Inc.Biofrontera AG announces initiation of clinical studiesNASDAQ:BFRABiofrontera AG
      11/10/20219:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
      11/09/202110:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BFRABiofrontera AG
       Showing the most relevant articles for your search:NASDAQ:BFRA